T-Cadherin Is an Auxiliary Negative Regulator of EGFR Pathway Activity in Cutaneous Squamous Cell Carcinoma: Impact on Cell Motility
Journal of Investigative Dermatology, 07/31/2012
Kyriakakis E et al. – The action of T–cadherin (T–cad) in squamous cell carcinoma (SCC) may serve as a paradigm explaining other malignancies displaying concomitant T–cad loss and enhanced EGFR activity.



